The FDA has granted accelerated approval to Wegovy® (semaglutide) as the first treatment for MASH with moderate-to-advanced ...

“KPop Demon Hunters” made me sigh with relief: Hybrids, mash-ups, whatever you want to call it, are no longer a freak show ...

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

The new approval allows the GLP-1 to be used to treat adults with the liver disease metabolic dysfunction-associated steatohepatitis (MASH) and liver scarring. Wegovy is the first GLP-1 to receive ...

Amateur fossil hunter Ross Dullard, who found the partial skull, says he will celebrate with a whale-themed party, marking ...

Yankees can mash, but playoffs will expose run prevention weakness again originally appeared on Athlon Sports. The Yankees ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

GAAP loss per share of ($0.12) in Q2 2025 beat expectations, driven by a sharp drop in research and development costs. No revenue reported, reflecting ongoing clinical-stage operations and focus on ...

The Herald (Top Stories) Walter Nyamukondiwa-Mashonaland West Bureau Chief Mashonaland West Provincial Affairs and Devolution ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...

Old No. 7 is an icon, but Jack Daniel's flavors aren't half bad. So how does its new Tennessee Blackberry whiskey stack up?